News >

Expert Highlights Advances in CAR T-Cell Therapy

Angelica Welch
Published: Tuesday, Dec 05, 2017

One of my goals is to spread the understanding that these therapies are very helpful for certain groups of patients—for the community oncologist to start thinking about these therapies for their patients. The other thing I really do want to communicate is the potential treatment-related toxicities because they are significant. Therefore, when that community oncologist starts to have a conversation with their patient, they will be well informed not only about the benefits, but also about the potential side effects. 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Cancer Summaries and Commentaries™: Update from San Diego - Advances in the Treatment of Multiple MyelomaJan 31, 20181.5
Publication Bottom Border
Border Publication